Search PubMed⌕ Search

Biomedical subjects

I Ziment

Publications and source records attributed to I Ziment.

At least 37 records · Page 2Linked to original sources
PubMed1987

Theophylline and mucociliary clearance.

Abnormal mucociliary transport is improvement by the action of theophylline, and this effect can be attributed to several mechanisms. The drug may directly and indirectly mediate the increase in the secretory output of bronchial glands, and this effect is enhanced by the vagal gastropulmonary reflex which is stimulated by the irritant action of theophylline on the stomach. Theophylline can increase the transepithelial secretion of fluid into the respiratory tract lumen by stimulating the chloride pump which is controlled by cyclic AMP. Ciliary motility is stimulated by theophylline; most of this effect is confined to the proximal part of the respiratory tree. However, much of the improvement in mucociliary clearance may be a consequence of the bronchodilation induced by theophylline, since the improved airway patency is generally a prerequisite for enhanced mucokinesis. Nevertheless, the multiple sites of action of theophylline in the respiratory tract suggests that this drug should be considered to be of significant value in any disorder characterized by mucostasis.

Aminophylline↗
PubMed1987

Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.

Nebulized bitolterol solution and isoproterenol solution were compared when used on a regular basis, 2.5 mg three times a day for 1 month by patients with chronic asthma. In this multicenter, double-blind trial; 130 nonsteroid-dependent patients were randomized to receive one of the two treatments concomitantly with their regular asthma medications. On study days, at the beginning of the study and after 2 and 4 weeks, treatments were given in the office or laboratory and patients were monitored with pulmonary function tests for eight hours. Both medications induced rapid bronchodilation that had a longer duration after bitolterol. The incidence of tremor was similar with the two medications. Tachycardia and palpitations were more frequent following isoproterenol. Bitolterol has a much longer duration of action and should be considered as a suitable bronchodilator for regular nebulizer treatment of chronic asthma.

Adolescent↗
PubMed1986

Acetylcysteine: a drug with an interesting past and a fascinating future.

N-acetylcysteine (NAC) possesses a free sulfhydryl group that can rupture disulfide bridges. Although it is considered to be a mucolytic, its mucokinetic actions include expectorant, bronchorrheic and mucoregulatory contributions. New uses include the management of acetaminophen poisoning and the scavenging of free radicals liberated by cancer chemotherapy drugs. The antioxidant effects may be of prophylactic value in lungs at risk from smoking, pollution and infection. Other uses proposed for NAC include the therapy of connective tissue diseases and its use as a component in life extension diets.

Acetylcysteine↗
PubMed1986

Respiratory pharmacology. Anticholinergic agents.

Although the anticholinergic agents are among the oldest of all respiratory drugs, they have been used only rarely in recent years. However, newer derivatives may have an important role in the treatment of bronchospastic diseases. The pharmacology of these interesting drugs is reviewed, with an emphasis on the therapeutic role of ipratropium.

Animals↗
PubMed1986

Respiratory pharmacology. Steroids.

Although glucocorticoids are widely used in the treatment and prophylaxis of asthma and other respiratory diseases, questions as to their mechanisms of action and their effectiveness continue to provoke debate. Controversies also exist in the selection of individual steroid preparations, dosages, and methods of delivery. These concerns are examined from the basis of the pharmacologic actions of these potent drugs.

Anti-Inflammatory Agents↗
PubMed1982

Management of respiratory problems in the aged.

Drug therapy of asthma in the elderly with sympathomimetics, theophylline, steroids, and mucokinetic agents is described, with discussion of dosage evaluation, toxicity, possible drug interactions, and suggested management of common problems. The aspirin hypersensitivity syndrome is reviewed, with an admonition to avoid this drug in asthmatic patients who have nasal polyps, nasal obstruction, or sinusitis, especially patients over the age of 30. The treatments of coughs and colds, and common respiratory infections such as tuberculosis and bronchitis, in the elderly are also outlined. Antihistamines are not advised for elderly patients who have viral or bacterial infections of the nose or throat, and oral preparations containing nasal mucosal vasoconstrictors should also be avoided in managing the elderly patient who has hypertension, vascular disease, or prostatism. Cough suppressants must be used with care, especially if cough is associated with chronic obstructive pulmonary disease. Special attention is given to the role of oxygen therapy for chronic obstructive pulmonary disease.

Aged↗
PubMed1978

A graphic approach to assessing interrelationships among minute ventilation, arterial carbon dioxide tension, and ratio of physiologic dead space to tidal volume in patients on respirators.

A graphic analysis of the relationships among minute ventilation, arterial PCO2, and the ratio of physiologic dead space to tidal volume is presented for the bedside clinical evaluation of patients receiving continuous respiratory support. With simultaneous measurement of minute ventilation and arterial PCO2, the graph can be used to determine the patient's ratio of dead space to tidal volume. This information can subsequently be used (1) for respirator adjustments to obtain the desired arterial PCO2; (2) to assess the severity of ventilation/perfusion unevenness; and (3) to follow the patient's response to respiratory therapy. It provides the clinician with a conceptual tool with which he can assess the status of a patient's gas exchange and more accurately evaluate and plan his course of treatment.

Carbon Dioxide↗
PubMed1977

Comparison of the bronchodilator effects of oral therapy with fenoterol hydrobromide and ephedrine.

Fenoterol hydrobromide (Berotec; formerly Th 1165a) is a sympathomimetic bronchodilator drug. Twenty subjects with mild to moderate reversible bronchospasm completed a double-blind multiple crossover study of single doses of 5 mg, 7.5 mg, and 10 mg of fenoterol hydrobromide, 24 mg of ephedrine, and placebo. Spirometric and body-plethysmographic measurements were performed sequentially prior to administration of drug or placebo and each hour up to eight hours afterwards. No significant drug-response relationship was noted for pulse rate or blood pressures, and side effects (eg, shakiness, nervousness) were minimal. Administration of fenoterol resulted in bronchodilation; a peak effect was noted at two to three hours after administration, and the duration of action was up to eight hours. A statistically significant dose-response relationship was observed; therapy with 5 mg of fenoterol hydrobromide was superior to placebo and equal to ephedrine, and doses of 7.5 mg and 10 mg of fenoterol hydrobromide were significantly better than placebo or ephedrine.

Administration, Oral↗
PubMed1977

Comparison of the bronchodilator effects of aerosol fenoterol and isoproterenol.

Aerosolized fenoterol in a dosage of 400 microgram was compared to isoproterenol 150 microgram in 31 asthmatic subjects during the course of a double-blind parallel 90-day study. Bronchodilator activities of the two drugs were evaluated for up to 6 hours on days 1, 45 and 90. Analysis of the data revealed that fenoterol consistently produced a significantly greater increase in FEV1, FEF25-75% and Gaw/VL. Specific airway conductance increased on each test day 25 percent or more above baseline for over three hours after use of fenoterol and for only one hour after use of isoproterenol. Fenoterol has less effect upon the cardiovascular and central nervous systems, but produced a greater incidence of shaking compared to isoproterenol. Patients used fenoterol less frequently than isoproterenol which can be attributed to the former having a greater peak effect and time course of bronchodilation. The therapeutic efficacy of fenoterol was sustained throughout this three-month study, and suggests that this relatively selective beta2 adrenergic drug will provide a well tolerated, alternative aerosol for chronic use in asthma.

Adult↗